175 related articles for article (PubMed ID: 25560589)
1. The effect of central noradrenergic system lesion on dopamine (DA) and serotonin (5-HT) synthesis rate following administration of 5-HT3 receptor ligands in chosen parts of the rat brain.
Roczniak W; Babuśka-Roczniak M; Kwapuliński J; Brodziak-Dopierała B; Widuchowski W; Cipora E; Nowak P; Oświęcimska JM
Pharmacol Rep; 2015 Feb; 67(1):146-51. PubMed ID: 25560589
[TBL] [Abstract][Full Text] [Related]
2. Assessment of dopamine (DA) synthesis rate in selected parts of the rat brain with central noradrenergic lesion after administration of 5-HT3 receptor ligands.
Roczniak W
Postepy Hig Med Dosw (Online); 2013 Jul; 67():648-52. PubMed ID: 24018429
[TBL] [Abstract][Full Text] [Related]
3. Influence of central noradrenergic system lesion on the serotoninergic 5-HT3 receptor mediated analgesia in rats.
Roczniak W; Wróbel J; Dolczak L; Nowak P
Adv Clin Exp Med; 2013; 22(5):629-38. PubMed ID: 24285447
[TBL] [Abstract][Full Text] [Related]
4. Conditional involvement of striatal serotonin3 receptors in the control of in vivo dopamine outflow in the rat striatum.
Porras G; De Deurwaerdère P; Moison D; Spampinato U
Eur J Neurosci; 2003 Feb; 17(4):771-81. PubMed ID: 12603267
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the analgesic effect of morphine on models of acute nociceptive pain in rats with a central noradrenergic system lesion.
Roczniak W; Oswiecimska JM; Brodziak-Dopierala B; Cipora E; Nowak PG; Babuska-Roczniak M
Neuro Endocrinol Lett; 2016 Jul; 37(3):239-244. PubMed ID: 27618597
[TBL] [Abstract][Full Text] [Related]
6. Multiple opioid receptors mediate the hypotensive response induced by central 5-HT(3) receptor stimulation.
Fregoneze JB; Oliveira EF; Ribeiro VF; Ferreira HS; De Castro E Silva E
Neuropeptides; 2011 Jun; 45(3):219-27. PubMed ID: 21514668
[TBL] [Abstract][Full Text] [Related]
7. Involvement of 5-HT3 receptors in the action of vortioxetine in rat brain: Focus on glutamatergic and GABAergic neurotransmission.
Riga MS; Sánchez C; Celada P; Artigas F
Neuropharmacology; 2016 Sep; 108():73-81. PubMed ID: 27106166
[TBL] [Abstract][Full Text] [Related]
8. Behavioral effects of the 5-hydroxytryptamine3 receptor agonists 1-phenylbiguanide and m-chlorophenylbiguanide in rats.
Higgins GA; Joharchi N; Sellers EM
J Pharmacol Exp Ther; 1993 Mar; 264(3):1440-9. PubMed ID: 8450478
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous determination of in vivo hydroxylation of tyrosine and tryptophan in rat striatum by microdialysis-HPLC: relationship between dopamine and serotonin biosynthesis.
Hashiguti H; Nakahara D; Maruyama W; Naoi M; Ikeda T
J Neural Transm Gen Sect; 1993; 93(3):213-23. PubMed ID: 7692885
[TBL] [Abstract][Full Text] [Related]
10. Bidirectional amygdaloid control of neuropathic hypersensitivity mediated by descending serotonergic pathways acting on spinal 5-HT3 and 5-HT1A receptors.
Sagalajev B; Bourbia N; Beloushko E; Wei H; Pertovaara A
Behav Brain Res; 2015 Apr; 282():14-24. PubMed ID: 25557801
[TBL] [Abstract][Full Text] [Related]
11. Isoflurane inhibits bronchopulmonary C-fiber-mediated apneic response to phenylbiguanide by depressing 5-HT3 receptor function in anesthetized rats.
Zhang Z; Zhuang J; Zhang C; Xu F
Neurosci Lett; 2013 Sep; 552():1-4. PubMed ID: 23896531
[TBL] [Abstract][Full Text] [Related]
12. Biosynthesis of dopamine and serotonin in the rat brain after repeated cocaine injections: a microdissection mapping study.
Baumann MH; Raley TJ; Partilla JS; Rothman RB
Synapse; 1993 May; 14(1):40-50. PubMed ID: 8511717
[TBL] [Abstract][Full Text] [Related]
13. Withdrawal from chronic ethanol increases the sensitivity of presynaptic 5-HT(1A) receptors modulating serotonin and dopamine synthesis in rat brain in vivo.
Esteban S; Moranta D; Sastre-Coll A; Miralles A; García-Sevilla JA
Neurosci Lett; 2002 Jun; 326(2):121-4. PubMed ID: 12057843
[TBL] [Abstract][Full Text] [Related]
14. Role of 5-HT3 receptors in basal and K(+)-evoked dopamine release from rat olfactory tubercle and striatal slices.
Zazpe A; Artaiz I; Del Río J
Br J Pharmacol; 1994 Nov; 113(3):968-72. PubMed ID: 7858893
[TBL] [Abstract][Full Text] [Related]
15. Chronic treatment and withdrawal of the cannabinoid agonist WIN 55,212-2 modulate the sensitivity of presynaptic receptors involved in the regulation of monoamine syntheses in rat brain.
Moranta D; Esteban S; García-Sevilla JA
Naunyn Schmiedebergs Arch Pharmacol; 2009 Jan; 379(1):61-72. PubMed ID: 18709357
[TBL] [Abstract][Full Text] [Related]
16. Neonatal co-lesion by DSP-4 and 5,7-DHT produces adulthood behavioral sensitization to dopamine D(2) receptor agonists.
Nowak P; Nitka D; Kwieciński A; Jośko J; Drab J; Pojda-Wilczek D; Kasperski J; Kostrzewa RM; Brus R
Pharmacol Rep; 2009; 61(2):311-8. PubMed ID: 19443944
[TBL] [Abstract][Full Text] [Related]
17. Effects of chronic administration of ondansetron (GR38032F), a selective 5-HT3 receptor antagonist, on monoamine metabolism in mesolimbic and nigrostriatal dopaminergic neurons and on striatal D2-receptor binding.
Koulu M; Lappalainen J; Hietala J; Sjöholm B
Psychopharmacology (Berl); 1990; 101(2):168-71. PubMed ID: 2140903
[TBL] [Abstract][Full Text] [Related]
18. Characterisation of c-Fos expression in the central nervous system of mice following right atrial injections of the 5-HT3 receptor agonist phenylbiguanide.
de Vries A; Paton JF; Lightman SL; Lowry CA
Auton Neurosci; 2005 Dec; 123(1-2):62-75. PubMed ID: 16298172
[TBL] [Abstract][Full Text] [Related]
19. Sleep Deprivation-Induced Blood-Brain Barrier Breakdown and Brain Dysfunction are Exacerbated by Size-Related Exposure to Ag and Cu Nanoparticles. Neuroprotective Effects of a 5-HT3 Receptor Antagonist Ondansetron.
Sharma A; Muresanu DF; Lafuente JV; Patnaik R; Tian ZR; Buzoianu AD; Sharma HS
Mol Neurobiol; 2015 Oct; 52(2):867-81. PubMed ID: 26133300
[TBL] [Abstract][Full Text] [Related]
20. Breathing stimulation mediated by 5-HT
Iovino L; Mutolo D; Cinelli E; Contini M; Pantaleo T; Bongianni F
Brain Res; 2019 Feb; 1704():26-39. PubMed ID: 30244021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
